Close Window
Aetna.com Home    |     Help    |     Contact Us

Search  
Aetna Aetna
Clinical Policy Bulletin:
Breast Reconstructive Surgery
Number: 0185


Policy

  1. Aetna considers reconstructive breast surgery medically necessary after a medically necessary mastectomy or a medically necessary lumpectomy that results in a significant deformity (i.e., mastectomy or lumpectomy for treatment of or prophylaxis for breast cancer and mastectomy or lumpectomy performed for chronic, severe fibrocystic breast disease, also known as cystic mastitis, unresponsive to medical therapy).  Medically necessary procedures include mastopexy, insertion of breast prostheses, the use of tissue expanders, or reconstruction with a transverse rectus abdominis myocutaneous (TRAM) flap, deep inferior epigastric perforator (DIEP) flap, or similar procedure.

  2. Aetna considers associated nipple and areolar reconstruction and tattooing of the nipple area medically necessary. Reduction (or some cases augmentation) mammoplasty and related reconstructive procedures on the unaffected side for symmetry are also considered medically necessary.

  3. Aetna considers breast reconstructive surgery to correct breast asymmetry cosmetic except for: (i) surgical correction of chest wall deformity causing functional deficit in Poland syndrome when criteria are met in CPB 272 - Pectus Excavatum and Poland’s Syndrome: Surgical Correction; or (ii) repair of breast asymmetry due to a medically necessary mastectomy or a medically necessary lumpectomy that results in a significant deformity; or (iii) prompt* repair of breast asymmetry due to trauma. (*Note: See CPB 031 - Cosmetic Surgery for criteria related to surgical repair of cosmetic disfigurement due to trauma).

See also CPB 017 - Breast Reduction Surgery and Gynecomastia Surgery.



Background

Breast reconstruction using autologous tissue is most commonly performed using the TRAM flap. This flap has been in use for 20 years and has provided excellent aesthetic results. However, a drawback of the TRAM flap is related to donor site morbidity of the abdomen. The pedicle TRAM flap frequently requires use of the entire rectus abdominis muscle, while the free TRAM flap requires use of as little as a postage-stamp size portion of the muscle. Abdominal complications resulting from a sacrifice of all or a portion of the rectus abdominis muscle include a reduction in abdominal strength (10-50%), abdominal bulge (5-20%), and hernia (< 5%).

Perforator flaps have gained increasing attention with the realization that the muscle component of the TRAM flap does not add to the quality of the reconstruction and serves only as a carrier for the blood supply to the flap. Thus, the concept of separating the flap (skin, fat, artery, and vein) from the muscle was realized as a means of minimizing the morbidity related to the abdominal wall and maintaining the aesthetic quality of the reconstruction. The deep inferior epigastric perforator (DIEP) flap was introduced in the early 1990's and is identical to the free TRAM flap except that it contains no muscle or fascia. Use of this flap has been popular in the Europe for a number of years and is now gaining popularity in the United States. The DIEP flap has been performed at Johns Hopkins for several years. Candidates for this operation are similar to those for the free TRAM in that there must be adequate abdominal fat to create a new breast. However, caution must be exercised in performing this technique in women who require large volume reconstruction to prevent the occurrence of fat necrosis or hardening of the new breast. The operation can be performed immediately following mastectomy or on a delayed basis. Performance of this operation is slightly more difficult than the free TRAM flap because it requires meticulous dissection of the perforating vessels from the muscle.

DIEP flaps tend to have less robust blood flow than is typical with a standard TRAM reconstruction, so careful patient selection is important. In patients who are nonsmokers, who require no more than 70% of the TRAM flap skin paddle to make a breast of adequate size, and who have at least one perforating vessel >1 mm in diameter with a detectable pulse, the incidence of flap complications reportedly is similar to that seen in standard free TRAM flap reconstruction.

Superior gluteal artery perforator (SGAP) flaps may be performed on women who are not candidates for a TRAM flap or who have had a failed TRAM flap. Thin women who may not have much tissue in the lower abdominal area often have an adequate amount of tissue in the gluteal region. The inferior gluteal artery perforator (SGAP) flap shares the same indications as the superior gluteal flap, namely the inability to use the TRAM flap and an abundance of soft tissue in the gluteal region.

Poland Syndrome is an extremely rare developmental disorder that is present at birth (congenital). It is characterized by absence (agenesis) or underdevelopment (hypoplasia) of certain muscles of the chest (e.g., pectoralis major, pectoralis minor, and/or other nearby muscles), and abnormally short, webbed fingers (symbrachydactyly). Additional findings may include underdevelopment or absence of one nipple (including the darkened area around the nipple [areola]) and/or patchy hair growth under the arm (axilla). In females, one breast may also be underdeveloped (hypoplastic) or absent (amastia). In some cases, affected individuals may also exhibit underdeveloped upper ribs and/or an abnormally short arm with underdeveloped forearm bones (i.e., ulna and radius) on the affected side. In most cases, physical abnormalities are confined to one side of the body (unilateral). In approximately 75 percent of the cases, the right side of the body is affected. The range and severity of symptoms may vary from case to case. The exact cause of Poland Syndrome is not known.

 
CPT Codes / HCPCS Codes / ICD-9 Codes
CPT codes covered if selection criteria are met:
11920
11921
+ 11922
11970
11971
19316
19318
19324
19325
19328
19330
19340
19342
19350
19355
19357
19361
19364
19366
19367
19368
19369
19370
19371
19380
19396
Other CPT codes related to the CPB:
19120 - 19126
19300 - 19307
21740 - 21743
HCPCS codes covered if selection criteria are met:
L8020 - L8039 Breast prostheses
L8600 Implantable breast prosthesis, silicone or equal
S2068 Breast reconstruction with deep inferior epigastric perforator (DIEP) flap or superficial inferior epigastric artery (SIEA) flap, including harvesting of the flap, microvascular transfer, closure of donor site and shaping the flap into a breast, unilateral
ICD-9 codes covered if selection criteria are met:
174.0 - 175.9 Malignant neoplasm of breast
198.81 Secondary malignant neoplasm of breast
233.0 Carcinoma in situ of breast
610.1 Diffuse cystic mastopathy [severe fibrocystic disease]
V10.3 Personal history of malignant neoplasm of breast
V45.71 Acquired absence of breast [following medically necessary mastectomy or lumpectomy resulting in significant deformity]
Other ICD-9 codes related to the CPB:
611.8 Other specified disorders of breast [acquired deformity NOS]
738.3 Acquired deformity of chest and rib [pectus excavatum]
754.81 Pectus excavatum [congenital]
756.3 Other anomalies of ribs and sternum [related to Poland's syndrome]
756.81 Absence of muscle and tendon [related to Poland's syndrome]
757.6 Specified anomalies of breast [hypoplasia breast] [congenital deformity NOS]
V16.3 Family history of malignant neoplasm of breast [related to prophylactic mastectomy]


The above policy is based on the following references:
  1. Kotwall CA. Breast cancer treatment and chemoprevention. Can Fam Physician. 1999;45:1917-1924.
  2. Polednak AP. Postmastectomy breast reconstruction in Connecticut: Trends and predictors. Plast Reconstr Surg. 1999;104(3):669-673.
  3. Brandberg Y, Malm M, Rutqvist LE, et al. A prospective randomised study (named SVEA) of three methods of delayed breast reconstruction. Study, design, patients' preoperative problems and expectations. Scand J Plast Reconstr Surg Hand Surg. 1999;33(2):209-216.
  4. Delay E, Jorquera F, Pasi P, Gratadour AC. Autologous latissimus breast reconstruction in association with the abdominal advancement flap: A new refinement in breast reconstruction. Ann Plast Surg. 1999;42(1):67-75.
  5. Spear SL, Pennanen M, Barter J, Burke JB. Prophylactic mastectomy, oophorectomy, hysterectomy, and immediate transverse rectus abdominis muscle flap breast reconstruction in a BRCA- 2-positive patient. Plast Reconstr Surg. 1999;103(2):548-553; discussion 554-555.
  6. Yeh KA, Lyle G, Wei JP, Sherry R. Immediate breast reconstruction in breast cancer: Morbidity and outcome. Am Surg. 1998;64(12):1195-1199.
  7. Papp C, Wechselberger G, Schoeller T. Autologous breast reconstruction after breast-conserving cancer surgery. Plast Reconstr Surg. 1998;102(6):1932-1936; discussion 1937-1938.
  8. Chavoin JP, Grolleau JL, Lanfrey E, Lavigne B. Breast reconstruction after mastectomy for cancer. Rev Prat. 1998;48(1):67-70.
  9. Delay E, Gounot N, Bouillot A, Zlatoff P, et al. Autologous latissimus breast reconstruction: A 3-year clinical experience with 100 patients. Plast Reconstr Surg. 1998;102(5):1461-1478.
  10. Bostwick J. Breast reconstruction after mastectomy and breast implants. Current status in the USA. Ann Chir Plast Esthet. 1997;42(2):100-106.
  11. Salmon RJ. Evolution of the surgery of cancer of the breast. Bull Cancer. 1998;85(6):539-543.
  12. Strozzo MD. An overview of surgical management of stage I and stage II breast cancer for the primary care provider. Lippincotts Prim Care Pract. 1998;2(2):160-169.
  13. Hidalgo DA, Borgen PJ, Petrek JA, et al. Immediate reconstruction after complete skin-sparing mastectomy with autologous tissue. J Am Coll Surg. 1998;187(1):17-21.
  14. Evans GR, Kroll SS. Choice of technique for reconstruction. Clin Plast Surg. 1998;25(2):311-316.
  15. Papp C, McCraw JB. Autogenous latissimus breast reconstruction. Clin Plast Surg. 1998;25(2):261-266.
  16. Kroll SS. Bilateral breast reconstruction. Clin Plast Surg. 1998;25(2):251-259.
  17. Serletti JM, Moran SL. The combined use of the TRAM and expanders/implants in breast reconstruction. Ann Plast Surg. 1998;40(5):510-514.
  18. Bhatty MA, Berry RB. Nipple-areola reconstruction by tattooing and nipple sharing. Br J Plast Surg. 1997;50(5):331-334.
  19. Blondeel PN. One hundred free DIEP flap breast reconstructions: A personal experience. Br J Plast Surg. 1999;52(2):104-111.
  20. Feller AM. Reconstruction of the female breast with free transverse lower abdominal flap as perforator flap. Langenbecks Arch Chir Suppl Kongressbd. 1998;115:971-972.
  21. Hamdi M, Weiler-Mithoff EM, Webster MH. Deep inferior epigastric perforator flap in breast reconstruction: Experience with the first 50 flaps. Plast Reconstr Surg. 1999;103(1):86-95.
  22. Blondeel PN, Boeckx WD. Refinements in free flap breast reconstruction: The free bilateral deep inferior epigastric perforator flap anastomosed to the internal mammary artery. Br J Plast Surg. 1994;47(7):495-501.
  23. National Organization for Rare Disorders, Inc. (NORD). Poland syndrome. In: NORD Rare Disease Database. New Fairfield, CT:  NORD; 1996. Availableat:http://www.stepstn.com/cgi-win/nord.exe?proc=Redirect&type=rdb_sum&id=440.htm. Accessed February 15, 2002.
  24. Blondeel PN, Demuynck M, Mete D, et al. Sensory nerve repair in perforator flaps for autologous breast reconstruction: Sensational or senseless? Br J Plast Surg. 1999;52(1):37-44.
  25. Blondeel N, Vanderstraeten GG, Monstrey SJ, et al. The donor site morbidity of free DIEP flaps and free TRAM flaps for breast reconstruction. Br J Plast Surg. 1997;50(5):322-330.
  26. Nahabedian MY, Dooley W, Singh N, et al. Contour abnormalities of the abdomen after breast reconstruction with abdominal flaps: The role of muscle preservation. Plast Reconstr Surg. 2002;109(1):91-101.
  27. Yap LH, Whiten SC, Forster A, et al. The anatomical and neurophysiological basis of the sensate free TRAM and DIEP flaps. Br J Plast Surg. 2002;55(1):35-45.
  28. Guzzetti T, Thione A. Successful breast reconstruction with a perforator to deep inferior epigastric perforator flap. Ann Plast Surg. 2001;46(6):641-643.
  29. Keller A. The deep inferior epigastric perforator free flap for breast reconstruction. Ann Plast Surg. 2001;46(5):474-480.
  30. Kroll SS. Fat necrosis in free transverse rectus abdominis myocutaneous and deep inferior epigastric perforator flaps. Plast Reconstr Surg. 2000;106(3):576-583.
  31. Rainsbury RM. Breast-sparing reconstruction with latissimus dorsi miniflaps. Eur J Surg Oncol. 2002;28(8):891-895.
  32. Sauven P; Association of Breast Surgery Family History Guidelines Panel. Guidelines for the management of women at increased familial risk of breast cancer. Eur J Cancer. 2004;40(5):653-665.
  33. Fischbacher C. Immediate versus delayed breast reconstruction. STEER: Succint and Timely Evaluated Evidence Reviews. Bazian, Ltd., eds. London, UK: Wessex Institute for Health Research and Development, University of Southampton; 2002; 2(17):1-18.
  34. Edlich RF, Winters KL, Faulkner BC, et al. Advances in breast reconstruction after mastectomy. J Long Term Eff Med Implants. 2005;15(2):197-207.
  35. Fentiman IS, Hamed H. Breast reconstruction. Int J Clin Pract. 2006;60(4):471-474.
  36. Javaid M, Song F, Leinster S, et al. Radiation effects on the cosmetic outcomes of immediate and delayed autologous breast reconstruction: An argument about timing. J Plast Reconstr Aesthet Surg. 2006;59(1):16-26.
  37. Chang DS, McGrath MH. Management of benign tumors of the adolescent breast. Plast Reconstr Surg. 2007;120(1):13e-19e.
  38. National Institute for Health and Clinical Excellence (NICE). Laparoscopic mobilisation of the greater omentum for breast reconstruction. Interventional Procedure Guidance 253. London, UK: NICE; 2008.


email this page   


Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.
Aetna
Back to top